Healthcare Technical Due Diligence: Assessing a New Cancer Treatment

Assessing Clinical Result of Small Molecule Inhibitor

Challenge

A major Korean biopharmaceutical company co-developed a new cancer treatment product with a partner and wanted to gather unbiased opinions on the results of its early clinical development from leading key opinion leaders (KOLs) in the oncology field.

The client could not engage the desired population through its existing network within the short time frame due to bandwidth constraint and the concern that it might disclose highly confidential information.

The GLG Approach

After speaking with KOLs in the U.S. oncology field and learning about the quality of GLG’s network, the client approached GLG.

Within a few days, GLG screened more than 400 U.S. oncologists and delivered a solid candidate list. From that list, the client selected optimal Network Members and GLG arranged screening calls to evaluate them.

The client had heightened concerns about the sharing of highly confidential information. As such, GLG worked closely with the client and a selected number of Network Members to address those concerns and reached a workable solution. GLG, as the facilitator of the entire consultation process, also shared the survey questionnaire to help the client gain expert opinion on the new product.

Outcome

The client confirmed engagement with three of the listed, leading oncologists who then provided in-depth written reports outlining their thoughts on the clinical development and technical feasibility of the product. They also shared their advice on the direction of the development going forward.

Why GLG?

GLG provided product development direction by connecting the client with top oncologists in the U.S.

Extensive Network

Biopharmaceutical companies can benefit from GLG’s extensive healthcare network, where they can find KOLs with relevant clinical experiences in specific oncology areas.

Assurance of Confidentiality

GLG has the proven ability to handle highly confidential projects with years of serving pharmaceutical clients engaged in advanced clinical research.

Timely Delivery

With a well-established network, GLG is able to deliver in-depth insights within a tight timeline even for projects that require complex legal and compliance considerations.

Let us start helping you today.

As the world’s insight network, GLG connects clients to the subject-matter experts who can provide real-world insights to make informed decisions. Our team of professionals work with you to create a tailored approach that identifies, assesses, and answers your questions on your timeline. We bring the power of insight to every great professional decision.

Thank you for contacting GLG, someone will respond to your inquiry as soon as possible.

Subscribe to Insights 360

Enter your email below and receive our monthly newsletter, featuring insights from GLG’s network of more than 900,000 professionals with first-hand expertise in every industry.